chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Thursday...3:05pm...metallic taste, sore/hot arm/beginning to swell... Tylenol taken Friday...5pm...severe chills, severe body aches, high fever, exhaustion, thirst until 2:30 am...Motrin taken at around 7pm...Dayquil taken around 1am Saturday 2:30 am chills subside, body aches continue, fever continues, exhaustion continues, thirst continues until 10am Saturday 10am fever subsides and sweating/clamminess begins, body aches subside. Tired Arm is still swollen at this time, burning and itching. Rash appears. Saturday 4pm no longer sweating, slight head ache Monday I still have a rash on the injection point and soreness and slight swelling. Still tired.
developed a fever and rash; developed a fever and rash; This spontaneous report has been received from a medical tech and refers to a 7-year-old male patient. The patient's pertinent medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided.  On 23-MAR-2017, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection (dose, dose number, frequency, route of administration vaccination scheme, anatomical location, lot number and expiration date were not provided), administered for routine vaccination and on 03-AUG-2023, he received the second dose.  On 13-AUG-2023, the patient developed a post-vaccination rash with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD). The patient received their first dose  with no issues, but with the second dose, he developed a fever and rash "an even rash around the hands, elbows, knees, and torso". The healthcare provider (HCP) was interested in varicella-zoster virus (VZV) analysis by polymerase chain reaction (PCR) and wanted to send viral isolates. The patient sought medical attention, it was unknown by the reporter if he received any treatment or if any laboratory diagnostics or studies were performed. The outcome of the events pyrexia and rash was not recovered.  The causality assessment between the events pyrexia and rash with the suspect vaccine Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was not reported.
REACTION TO VACCINE GIVEN IN TENDON; INAPPROPRIATE ROUTE OF VACCINATION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced reaction to vaccine given in tendon, and inappropriate route of vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the reaction to vaccine given in tendon and inappropriate route of vaccination was not reported. This report was non-serious.
3 patients received vaccine from vial that had been left out at room temperature and was punctured on 14 DEC 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received vaccine from vial that had been left out at room temperature and was punctured on 14 DEC 2021) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received vaccine from vial that had been left out at room temperature and was punctured on 14 DEC 2021). On 15-Dec-2021, EXPIRED PRODUCT ADMINISTERED (3 patients received vaccine from vial that had been left out at room temperature and was punctured on 14 DEC 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment information was not reported. Patient weight was 258 with unknown units. No other adverse reactions were reported.   This case was linked to MOD-2022-459158, MOD-2022-459165 (Patient Link).
There was not an adverse event but the 1st dose of Moderna was given. Patient did not report to nurse or clinic staff that he already received both doses of the Pfizer covid vaccine. Pt was contacted and the below is a conversation that was between the patient and the nurse (filling out this report) Pt came to an offsite  Covid Vaccine clinic on 6/23/2021 and asked for information on the Morderna vaccine. I went over all of the symptoms that he could possibly get after the vaccine. Pt asked if there was any more shots needed after the two doses. I explained to pt that at this time there are no other suggested doses after the 2nd dose has been given. Pt chose to get the Moderna vaccine and filled out the form answered all questions and signed for consent. When documenting took place after the vaccine was given it was found that this pt received 2 doses of the Pfizer vaccine. I did call health department and they investigated and confirmed this to be true. I contacted pt and updated him on the above info. Pt stated "I know i had the series of Pfizer. I wanted to get the Moderna as well because I'm scared of this virus and i wanted to be extra immune to it. I did a lot of research about getting multiple covid vaccines. They are doing this in other countries." Nurse advised pt that this is not recommended at this time here in and that this incident will have to be reported to VAERS and that he may be contacted to gather more information. Pt stated "That is fine." Nurse instructed pt that he should not receive the second dose of the Moderna at this time. Pt responded "I wasn't going to get the second one anyway because it made me sick. I had fever, chills, and felt miserable." Pt was instructed to contact our office if he has any concerns.
p/vax pt devel flu-like sx, fever, & chills;progressive pain in neuromuscular system which affected muscles, joints, connective tissue & burning sensation in hands & feet;latter sx became disabling affecting performance of ADLs;tx med;
CLIENT IS IMMUNOCOMPROMISED AND WAS RECEIVING A 1ST BOOSTER DOSE OF MODERNA (4TH VACCINATION). CLIENT WAS GIVEN A FULL MODERNA DOSE (0.5ML) INSTEAD OF A BOOSTER DOSE (0.25ML).
Left arm became itchy after vaccination injected . Sl red rash.  Benadryl 50 mg given
Diarrhea, loss of appetite and sores on buttocks from diarrhea. Symptoms started 1 1/2 hours, post vax, and lasted 10 days.
This spontaneous report was received from a licensed practical nurse regarding multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On an unknown dates, the patients were vaccinated with an improperly stored doses of (Merck) VARIVAX (dose, route, lot # and expiration date were not reported). There were no adverse effects reported. This is one of two reports received from the same source. Additional information has been requested.
broke out with itchy hives/hives on thighs, buttocks, legs, seat and back; broke out with itchy hives/hives on thighs, buttocks, legs, seat and back; This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (broke out with itchy hives/hives on thighs, buttocks, legs, seat and back) and PRURITUS (broke out with itchy hives/hives on thighs, buttocks, legs, seat and back) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included Mononucleosis (At age 21 (broke out in a fine red rash).). Concurrent medical conditions included Penicillin allergy.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced URTICARIA (broke out with itchy hives/hives on thighs, buttocks, legs, seat and back). On an unknown date, the patient experienced PRURITUS (broke out with itchy hives/hives on thighs, buttocks, legs, seat and back). At the time of the report, URTICARIA (broke out with itchy hives/hives on thighs, buttocks, legs, seat and back) and PRURITUS (broke out with itchy hives/hives on thighs, buttocks, legs, seat and back) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications included topical calming cream.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Mailing address updated.
On 04 Mar 2021 he started to break out with a rash. The rash was on his face, down to his neck, shoulders, pretty evenly on his scalp, and he still has the rash now; Tired and achy; Tired and achy; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (patient). A 77-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown), via an unspecified route of administration on 23Feb2021 (at the age of 77-years-old) as dose 2, single for COVID-19 immunisation. Medical history included heart surgery from an unknown date and unknown if ongoing. Concomitant medications were not reported. Patient received vaccination facility in clinic. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown) via an unknown route of administration, administered in left shoulder on 01Feb2021 2:00 PM as dose 1, single for COVID-19 immunisation. On 04Mar2021 he started to break out with a rash. The rash was on his face, down to his neck, shoulders, pretty evenly on his scalp, and he still has the rash now. someone in the background added the rash was to the ear. The rash was slightly better. He notices the rash breaks out more and is effected more by a warm shower. Thinks right thing to do. He was concerned about it because has severe health problems, his age, and he wanted to coincide with the recommended things provided from the CDC and the health organizations. He took medication related to blood pressure and prostate, no additional details provided. He took minor medications due to having heart surgery. The second shot 12 hours afterwards he felt tired and achy in Feb2021, does not know if that really matters. The tired and achy feeling went away within another 12 hours, it was not severe. Feeling tired and achy started in the middle of the night. He later mentioned if he gets the flu shot each year he may have a slight reaction sometimes, but no additional details provided. He has no lot/exp to provide from the Flu Shot. Patient not visited Emergency Room. Patient visited physician's office, due to the rash. He saw the doctor twice. First time was 10Mar2021 and again this morning. The first time saw the doctor it was recommended he use some creams and antihistamines. Now this morning the doctor was more suspicious the rash was related to the COVID vaccine. The outcome of the event rash was reported as recovering and while for other events was unknown.  No follow-up attempts are possible. No further information is expected.
About 45 minutes after receiving the vaccine, she developed a systemic rash followed by jives. Her right arm developed some swelling and then some numbness and stiffness. She states she developed a headache behind  her eyes. BP 131/75 at 1232 with HR 102 and Pulse Ox95. At 1237 BP 127/77, HR 104 and Pulse Ox 95. SHe was taken to the ED to be evaluated
I had a swollen lymph node approximately the size of a baseball that developed under my left armpit; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the first dose on BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number EJ1685), intramuscular in the left arm on 18Dec2020 10:00 AM (at the age of 41-years-old) as a single dose for COVID-19 immunization. Medical history included that the patient was diagnosed with COVID-19 prior to the vaccination. The patient did not have any allergies to medications, food, or other products. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient did not receive other medication in the two weeks prior to the vaccination. On 19Dec2020 14:00 PM, the patient experienced a swollen lymph node approximately the size of a baseball that developed under her left armpit. It took about 5 days to completely resolve. The patient did not receive any treatment for the event. The patient had not tested for COVID-19 post vaccination. The outcome of the event, swollen lymph node, was recovered, in Dec2020.
Lumps on right lower abdomen and spine. Hurts when I bend and lumps stick out.
3 days after receiving the second moderna vaccine I ended up in the emergency room due to dizziness.  Was diagnosed with vertigo.
2nd Vaccine was given early.  First dose given on 3/19/21 second does was due on 4/16/21 but was not due until 4/16/21
pt recvd vax & devel high fever; aching all over; loss of appetite; like  old fashion flu;
tiredness; nausea; body ache; This is a spontaneous report from a contactable consumer. This female consumer (patient) with unspecified age reported that she received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 12Jan2021 at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported. Historical vaccine included she experienced a similar reaction (unspecified) to the influenza vaccine for immunization in the past. In Jan2021, few days later the BNT162B2 vaccine, the patient experienced tiredness with outcome of recovered in Jan2021, nausea with outcome of recovered in Jan2021; a few weeks after the vaccine body ache with outcome of unknown.  Information on the lot/batch number has been requested.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Additional Details: After about 5 minutes after patient recieved COVID shot, he wasn't normal. He said he had lightheadness and chills and tingling. A few minutes later he went to the bathroom to vomit. Paramedic called because patient didn't seem well and patient said he needed medical attention. Paramedic came about 5-8 minutes. Patient left a few minutes after paramedic left.
Information has been received from a physician concerning a 12-month-old male who was recently vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live.  Concomitant vaccinations included a dose of varicella virus vaccine live and a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine.  One week after the vaccinations the patient developed hives, seizures and temperature of 102 degrees Fahrenheit.  Unspecified medical attention was sought and it was reported that the patient was hospitalized for three or more days.  The physician suspected the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live as cause.  No information was reported regarding the present status of the patient.  No product quality complaint was involved.  The physician considered the hives, seizures and temperature of 102 degrees Fahrenheit to be disabling.  Additional information has been requested.
This is a spontaneous report from a non-contactable Health Care Professional. A child of an unspecified age, gender and race, received, on an unknown date, the second dose of TRUMENBA single dose for immunization. Relevant medical history was unknown. Concomitant medication included influenza vaccine, for immunization. On an unspecified date, the patient experienced extreme fatigue (the child was sleeping and barely waking up). Clinical outcome was unknown at time of this report. No follow-up attempts possible. No further information expected.
Pt. received vac. 7/25/14 at 0915 AM. Pt. reported rash to bilateral arms from waist to elbow 7/25/14 at 1630 PM. Was seen by provider at urgent care on 7/25/14 evening, also 7/29/14 AM. F/u scheduled with MD 7/29/14 AM 0700.
Numbness and pain in right at site of shot. Pain dispersed through my arm and into my shoulder, armpit and gave sharp pains in the right side of my chest. The adverse effect came to my attention today when I hopped into the shower and noticed a huge lump underneath my right arm. It is a descent size and tender to the touch. Not hardened but softer to the touch like a water balloon. I remain very sore in my arm at injection site as well tender in my right ear, under arm, shoulder and neck.
sharp pain in left temple, comes on quickly and only lasts abut a minute, happens at least once a day, some days several times a day.
During 15 minute wait period past shots (vaccines), parent reported child was sweaty and sleepy. Noted child's palm moist but child responsive. Provided cool fan air and cool compress. Parent provided drink. Condition improved. Respirations 18, and heart rate 92 initially and past. The parent declined 911. Will monitor for problems at home. No past history of syncope after shots.
rash; shingles; rash and redness behind the ear; hypersensitivity reaction; This case was reported by a other health professional via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) (batch number 272M2, expiry date 7th December 2021) for prophylaxis.   On 6th April 2020, the patient received Shingrix. On 9th April 2020, 3 days after receiving Shingrix, the patient experienced rash, shingles, erythema and hypersensitivity reaction. On an unknown date, the outcome of the rash, shingles, erythema and hypersensitivity reaction were unknown.   It was unknown if the reporter considered the rash, shingles, erythema and hypersensitivity reaction to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient received Shingrix and 3 days later came back with a rash and redness behind the ear which she deemed to be a hypersensitivity reaction. Five days after that he presented with what appeared to be a case of shingles.
A non-serious spontaneous report of administration of expired med was received from a health professional concerning a 14-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 06-Dec-2010. The patient received the expired FLUMIST on 07-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. Additional information was received on 07-Mar-2011 and incorporated into case: no late occurring adverse events.
Patient states she developed a rash approximately two hours after receiving Hepatitis B vaccine to left deltoid and to inner middle arm. She denies any other symptoms. Today patient presents to clinic with redness and cellulitis to left deltoid about two inches from injection site area is warm to touch. Mild papular rash appears to inner middle arm and patient reports itching at site. Patient advised to seek prompt medical attention of symptoms persist or worsen, recommended patient apply cold compresess for relief.
Initial report received from a consumer on 23 January 2013. A patient of unspecified demographics, whose medical history and concomitant medications were not reported, had received a FLUZONE HD (lot number U4537AA, route, number in series and anatomical site of administration were not reported) on an unspecified date. On an unspecified date, patient had allergic reaction after vaccination. Corrective treatment and laboratory investigations were not reported. The patient's outcome was not reported. Follow-up information was received from a consumer on 15 April 2013. Based upon the new information, this case has been upgraded to serious. The patient was a 71-year-old male who received FLUZONE HIGH-DOSE on 23 January 2013 at 3:00 PM. Three hours later at 6:00 PM, the patient developed nausea, vomiting and a sensation of throat closing. The patient was diagnosed with uvulitis at the emergency room and treated with steroids. Outcome was recovered. Documents held by sender: none.
01/28/2023 symptoms; scratchy throat within 24 hours my symptoms became more severe. I had fatigue, body aches, congestion, headache, fever 101.0. Symptoms lasted for 2 weeks and I returned to urgent care on 02/09/2023, I was tested for Influenza and COVID-19 both results were negative. Physician did not prescribe any medication and throughout the day I was feeling worse. On 02/11/2023 I woke up with pink eye in both eyes and returned to urgent care and was prescribed a ZPAK and TYLENOL PRN.
Extremely high fever over 104F.  Every fever since then has been 104F or higher.
mild headache began within hours of vaccination. injection site pain, agitation, body aches/myalgias overnight, woke up morning after with fairly severe chills, nausea, weakness/dizziness, severe headache (like an ice pick stabbing between my ears), neck stiffness/inflammation, upper body on both sides painful, lower back pain, injection site pain, sore throat. Went to doctor thinking I had the flu, 102.8 temperature recorded, elevated blood pressure, throat redness, "classis covid presentation" per provider. Negative rapid flu test, negative rapid covid test, negative pcr covid test. Combo of tylenol/ibuprofen was advised, so I have taken the max allowable and slept nearly all day and most of the night.  second morning after 1/21/2021, still feeling ill, but not as bad as the day before, continuing to take combo of tylenol and ibuprofen as directed.
Pt c/o right shoulder rash w/ body aches and chills. Area became red and swollen approx. 6 days after vaccine. Pt advised to use ice 10-15 min prn and ADVIL OTC prn pain.
7/14/12 pt woke up with cellulitis near the right eye. Went to ER 7/16/12 after AUGMENTIN prescribed by PCP wasn't working. Treated in ER with IV antibiotics & continued at home with AUGMENTIN. ER physician wasn't completely sure that it was related to ZOSTAVAX administration.
later that night chest tightness, tender to the touch, heart fluttering, heart beat off rhythm
Patient stated the evening after he received his second dose (2 days ago on August 8th. 2018) of the SHINGRIX vaccine, he spiked a 101 fever. He also reported vomiting, nausea, and diarrhea. He states this was moderately bothersome. However, it lasted 1 evening and resolved. He is feeling better today.
Right arm was very sore. Fatigue and tiredness. He stated he was faint and spaced out. Off balanced and body aches. He said its hard to concentrate, he gets confused sometimes and he gets dizzy spells. Hurts to focus and loo at thinks. Fatigue and easily angered. Brain fogs and have a feeling of not wanting to do much anymore.
Employee called today stating that she is feeling  numbness and numbness on the entire right half of her body. Stated was going to see her PCP but did not give further indication of who.
The patient returned to our office approximately 1-2 hours after receiving flu shot, MMR, DTap, and IPV.  He had generalized urticarin, diffuse wheezing, and decreased blood pressure (88/64).  He was given 3 tsp Orapred, Benadryl 25 mg & Xspenex 1.25mg.  Ten minutes later wheezing & urticaria resolved and BP was 98/74.